CHRISTOPHER S HENNEY Insider Trading $CASC Cascadian Therapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for CHRISTOPHER S HENNEY.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of CHRISTOPHER S HENNEY. CHRISTOPHER S HENNEY is Director in BIO-TECHNE Corp ($TECH) and Chairman of the Board in DENDREON CORP ($DNDN) and Director in Cyclacel Pharmaceuticals, Inc. ($CYCC) and in Anthera Pharmaceuticals Inc ($ANTH) and Director in Oncothyreon Inc. ($ONTY) and Interim CEO and President in Oncothyreon Inc. ($ONTY) and Director in Prothena Corp plc ($PRTA).
CHRISTOPHER S HENNEY in Cascadian Therapeutics, Inc.
Industry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Position of CHRISTOPHER S HENNEY: Interim CEO and President, Director
Holdings: 0 shares
Latest Transaction: Mar 13 2018
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of CHRISTOPHER S HENNEY in Cascadian Therapeutics, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ANTH, TECH, CASC, CYCC, DNDN, PRTA
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 13 2018 | CASC | Cascadian Therapeu ... | HENNEY CHRISTOPHER S | Director | Option Exercise | D | 0.00 | 13,927 | 0 | 0 | |
| Mar 13 2018 | CASC | Cascadian Therapeu ... | HENNEY CHRISTOPHER S | Director | Option Exercise | D | 6.36 | 25,000 | 159,000 | 0 | |
| Mar 13 2018 | CASC | Cascadian Therapeu ... | HENNEY CHRISTOPHER S | Director | Sell | U | 0.00 | 60,185 | 0 | 0 | 60.2 K to 0 (-100.00 %) |
| Sep 26 2017 | CASC | Cascadian Therapeu ... | HENNEY CHRISTOPHER S | Director | Option Exercise | M | 0.00 | 2,375 | 0 | 0 | |
| Sep 26 2017 | CASC | Cascadian Therapeu ... | HENNEY CHRISTOPHER S | Director | Payment of Exercise | F | 3.94 | 594 | 2,340 | 60,185 | 60.8 K to 60.2 K (-0.98 %) |
| Sep 26 2017 | CASC | Cascadian Therapeu ... | HENNEY CHRISTOPHER S | Director | Buy | M | 0.00 | 2,375 | 0 | 60,779 | 58.4 K to 60.8 K (+4.07 %) |
| Jun 27 2017 | CASC | Cascadian Therapeu ... | HENNEY CHRISTOPHER S | Director | Option Exercise | M | 0.00 | 9,058 | 0 | 0 | |
| Jun 27 2017 | CASC | Cascadian Therapeu ... | HENNEY CHRISTOPHER S | Director | Payment of Exercise | F | 3.78 | 2,265 | 8,562 | 58,404 | 60.7 K to 58.4 K (-3.73 %) |
| Jun 27 2017 | CASC | Cascadian Therapeu ... | HENNEY CHRISTOPHER S | Director | Buy | M | 0.00 | 9,058 | 0 | 60,669 | 51.6 K to 60.7 K (+17.55 %) |
| Jun 13 2017 | CASC | Cascadian Therapeu ... | HENNEY CHRISTOPHER S | Director | Option Exercise | M | 0.00 | 2,148 | 0 | 0 | |
| Jun 13 2017 | CASC | Cascadian Therapeu ... | HENNEY CHRISTOPHER S | Director | Option Exercise | A | 0.00 | 13,927 | 0 | 13,927 | |
| Jun 13 2017 | CASC | Cascadian Therapeu ... | HENNEY CHRISTOPHER S | Director | Payment of Exercise | F | 3.34 | 537 | 1,794 | 51,611 | 52.1 K to 51.6 K (-1.03 %) |
| Jun 13 2017 | CASC | Cascadian Therapeu ... | HENNEY CHRISTOPHER S | Director | Buy | M | 0.00 | 2,148 | 0 | 52,148 | 50 K to 52.1 K (+4.30 %) |
| Feb 01 2017 | ONTY | Cascadian Therapeu ... | HENNEY CHRISTOPHER S | Director | Buy | P | 4.11 | 25,324 | 103,973 | 50,000 | 24.7 K to 50 K (+102.63 %) |
| Jun 28 2016 | ONTY | Cascadian Therapeu ... | HENNEY CHRISTOPHER S | Interim CEO and Pre ... | Option Exercise | A | 0.00 | 54,347 | 0 | 54,347 | |
| Mar 16 2016 | ONTY | Oncothyreon Inc. | HENNEY CHRISTOPHER S | Interim CEO and Pre ... | Option Exercise | A | 1.06 | 150,000 | 159,000 | 150,000 | |
| Sep 28 2015 | ONTY | Oncothyreon Inc. | HENNEY CHRISTOPHER S | Director | Option Exercise | A | 0.00 | 14,245 | 0 | 14,245 | |
| Jun 16 2015 | ONTY | Oncothyreon Inc. | HENNEY CHRISTOPHER S | Director | Option Exercise | M | 0.00 | 16,042 | 0 | 0 | |
| Jun 16 2015 | ONTY | Oncothyreon Inc. | HENNEY CHRISTOPHER S | Director | Option Exercise | A | 0.00 | 12,886 | 0 | 12,886 | |
| Jun 16 2015 | ONTY | Oncothyreon Inc. | HENNEY CHRISTOPHER S | Director | Payment of Exercise | F | 3.88 | 4,011 | 15,563 | 135,807 | 139.8 K to 135.8 K (-2.87 %) |
| Jun 16 2015 | ONTY | Oncothyreon Inc. | HENNEY CHRISTOPHER S | Director | Buy | M | 0.00 | 16,042 | 0 | 139,818 | 123.8 K to 139.8 K (+12.96 %) |
Page: 1